Granahan Investment Management KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Granahan Investment Management ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$7,092
+74.3%
552,350
+31.5%
0.23%
+66.9%
Q2 2022$4,070
-44.8%
419,995
-43.4%
0.14%
-24.0%
Q1 2022$7,377
+4.5%
742,158
+23.8%
0.18%
+26.2%
Q4 2021$7,056
+52.7%
599,522
+47.7%
0.14%
+64.8%
Q3 2021$4,622405,8340.09%